A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 - but only if between two and ...

Is long-acting HIV treatment as effective as daily pills? Early results say yes—with some risks of resistance in rare cases.

The Trump administration this week decimated HIV prevention programs across government health agencies after terminating ...

HIV outbreak in Kerala sparks fear and stigma among injecting drug users, prompting urgent response from health authorities.

South African scientists announce promising results from an HIV-cure trial, showing hope for long-term virus control without ...

If funding cuts continue, the world could face higher rates of annual new HIV infections by 2030 than at the peak of the ...

Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2025 Grad Slam event. This year’s ...

Professor Thumbi Ndung'u and his team at the Africa Health Research Institute are pioneering a study that explores innovative ...

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

The University of KwaZulu-Natal (UKZN) is set to host a crucial engagement session on Friday, April 5, focusing on a ...